Allen Radin
- Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthmaBy Sally Wenzel, Jeffrey Ming, Jennifer Hamilton, Allen Radin, Ross Rocklin, Thomas Hultsch, Lin Wang, Franck Skobieranda and Gianluca PirozziSally Wenzel1Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United StatesJeffrey Ming2Clinical Development, Sanofi, Bridgewater, NJ, United StatesJennifer Hamilton3Clinical Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United StatesAllen Radin3Clinical Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United StatesRoss Rocklin2Clinical Development, Sanofi, Bridgewater, NJ, United StatesThomas Hultsch4Clinical Development, Sanofi-Genzyme, Cambridge, MA, United StatesLin Wang2Clinical Development, Sanofi, Bridgewater, NJ, United StatesFranck Skobieranda2Clinical Development, Sanofi, Bridgewater, NJ, United StatesGianluca Pirozzi2Clinical Development, Sanofi, Bridgewater, NJ, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.